Varanakis Ann
Chief People Officer
Varanakis Ann has filed 5 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 26, 2026.
On the most recent filing, Varanakis Ann is listed as Chief People Officer at LifeStance Health Group, Inc. Inside the rolling window, Varanakis Ann reported no open-market purchases and 1 open-market sale totaling $345K in LFST.
Companies traded
Other insiders at LFST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$345K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Varanakis Ann made?
Varanakis Ann has filed 5 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.
Which companies does Varanakis Ann trade?
Varanakis Ann has filed SEC Form 4 disclosures for 1 company, including LFST.
When was Varanakis Ann's most recent SEC Form 4 filing?
Varanakis Ann's most recent SEC Form 4 filing on Tracefour is dated Aug 26, 2026.
What is Varanakis Ann's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Varanakis Ann is listed as Chief People Officer.
What is Varanakis Ann's total buy and sell value in the current window?
Inside the rolling retention window, Varanakis Ann bought $0 and sold $345K based on SEC Form 4 filings.
What was Varanakis Ann's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 LFST shares on 2025-12-17, worth $345K, per SEC Form 4 filings.